Insulin aspart, recombinant Subcutaneous and Loratadine
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Loratadine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: loratadine
Brand name: Alavert, Claritin, Claritin Reditab, Clear-Atadine, Dimetapp ND, Ohm Allergy Relief, QlearQuil All Day & Night, Tavist ND, Wal-itin
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Loratadine and pseudoephedrine
- Insulin aspart, recombinant Subcutaneous-Loratadine Capsules and Tablets
- Insulin aspart, recombinant Subcutaneous-Loratadine Chewable Tablets
- Insulin aspart, recombinant Subcutaneous-Loratadine Liquid
- Insulin aspart, recombinant Subcutaneous-Loratadine Oral Solution
- Insulin aspart, recombinant Subcutaneous-Loratadine Orally Disintegrating Tablets
- Loratadine-Insulin degludec
- Loratadine-Insulin Degludec (U-100) Prefilled Pens
- Loratadine-Insulin Degludec (U-100) Vials
- Loratadine-Insulin Degludec (U-200) Prefilled Pens
- Loratadine-Insulin degludec and liraglutide
- Loratadine-Insulin degludec and liraglutide Subcutaneous